Glenmark Pharmaceuticals Limited (BOM:532296)
India · Delayed Price · Currency is INR 2,035.90
+6.30 (0.31%)
At close: Dec 31, 2025
Glenmark Pharmaceuticals Employees
Glenmark Pharmaceuticals had 15,800 employees as of March 31, 2025. The number of employees increased by 811 or 5.41% compared to the previous year.
Employees
15,800
Change (1Y)
811
Growth (1Y)
5.41%
Revenue / Employee
10.12M INR
Profits / Employee
639.14K INR
Market Cap
571.80B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 15,800 | 811 | 5.41% |
| Mar 31, 2024 | 14,989 | -567 | -3.64% |
| Mar 31, 2023 | 15,556 | 141 | 0.91% |
| Mar 31, 2022 | 15,415 | 4,451 | 40.60% |
| Mar 31, 2021 | 10,964 | 297 | 2.78% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Tata Consultancy Services | 607,979 |
| Reliance Industries | 403,303 |
| Infosys | 323,578 |
| State Bank of India | 236,226 |
| HDFC Bank | 214,521 |
| ICICI Bank | 182,665 |
| Life Insurance Corporation of India | 91,606 |
| Bajaj Finance | 64,092 |
Glenmark Pharmaceuticals News
- 10 days ago - Glenmark Pharma launches Epinephrine Injection USP multiple-dose vial in the US - Business Upturn
- 16 days ago - Top stocks to watch today, December 17: Ola Electric, NBCC, Ahluwalia Contracts, Glenmark Pharma, BEML and more - Business Upturn
- 16 days ago - Glenmark Pharma enters licensing deal with Hansoh Pharma for lung cancer drug aumolertinib - Business Upturn
- 22 days ago - Glenmark Pharma to launch Leucovorin Calcium for Injection USP, 350 mg/vial in the U.S. market - Business Upturn
- 4 weeks ago - Glenmark’s Aurangabad Facility Clears US FDA Inspection With Zero Observations - Business Upturn
- 5 weeks ago - Glenmark Pharma receives US FDA EIR with VAI status for Monroe facility - Business Upturn
- 5 weeks ago - Glenmark Pharma launches world’s first bebulized triple therapy for COPD in India - Business Upturn
- 6 weeks ago - HSBC cuts Glenmark’s target price to Rs 2,110, says abnormal quarter driven by upfront ISB payment and India disruption - Business Upturn